Clinical Nutrition For Diabetes Care Market (2026 - 2033)

Clinical Nutrition for Diabetes Care Market Summary

The global clinical nutrition for diabetes care market size was valued at USD 2.4 billion in 2025 and is projected to grow from USD 2.5 billion in 2026 to USD 3.5 billion by 2033, growing at a CAGR of 4.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 34.0% in 2025. The increasing demand for specialized food products by individuals with diabetes or those at risk of developing the condition is a critical factor for the diabetes clinical nutrition market growth. This includes people with type 1 or type 2 diabetes, as well as those following a diabetic diet.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The rising prevalence of diabetes, driven by aging, obesity, sedentary lifestyles, and unhealthy dietary habits, is a major factor supporting the growth of the global clinical nutrition market. According to the International Diabetes Federation (IDF), approximately 589 million adults aged 20-79 years were living with diabetes worldwide in 2024, representing around 11.1% of the global adult population. This figure is projected to reach 853 million by 2050, reflecting the increasing global burden of the disease. Diabetes remains a leading cause of serious complications, including cardiovascular disease, chronic kidney disease, blindness, and lower-limb amputations, with risks increasing due to aging, obesity, physical inactivity, poor dietary habits, and inadequate glycemic control.

As the prevalence of diabetes and its associated complications continues to rise, healthcare providers are increasingly incorporating specialized clinical nutrition interventions to support glycemic control, improve nutritional status, and enhance long-term patient outcomes. Disease-specific medical foods, oral nutritional supplements, and enteral and parenteral nutrition play an important role in managing nutritional deficiencies and slowing disease progression in high-risk patients. Furthermore, a study by the University of Minnesota reported a 62% increase in the incidence of type 2 diabetes in the U.S. following the COVID-19 pandemic, particularly among children and adolescents aged 10-19 years, highlighting the growing need for effective nutritional management.

Growing consumer awareness, supportive public health initiatives, and increasing scientific evidence regarding the benefits of nutrition in diabetes management are further driving demand for diabetes-specific nutrition products. Consumers are increasingly seeking low-sugar, low-carbohydrate, and nutritionally balanced products that offer convenience without compromising taste, while many are willing to pay a premium for healthier alternatives. This shift in consumer preferences is expected to support sustained growth in the diabetes clinical nutrition market.

Analyst Perspective

The global clinical nutrition for diabetes care market is expected to witness significant growth during the forecast period, driven by the rising prevalence of diabetes, increasing obesity rates, and growing awareness of the benefits of medical nutrition therapy. Clinical nutrition plays a vital role in improving glycemic control, reducing cardiovascular risk factors, and supporting overall metabolic health, driving demand for diabetes-specific nutritional products. Healthcare professionals are increasingly incorporating nutrition-based interventions as part of comprehensive diabetes management to help prevent acute and long-term complications. Additionally, rising demand for personalized nutrition, expanding healthcare infrastructure, supportive government initiatives, and the development of low-glycemic, protein- and fiber-rich nutritional formulations are expected to create substantial growth opportunities for the market.

Product Insights

Oral clinical nutrition for diabetes care dominated the market in 2025 with a revenue share of around 72.0%. Oral nutritional therapy is vital for diabetes management as it significantly aids in controlling blood sugar levels, supports weight regulation, and helps avoid diabetes-related complications. There is substantial evidence indicating that oral nutrition therapy is both effective and cost-efficient when integrated into a holistic approach to diabetes care.

Enteral feeding formulas in diabetes care are expected to grow at the fastest pace over the forecast period. The demand for diabetes-specific enteral feeding formulas is on the rise, driven by numerous studies that attest to their efficacy in managing diabetes patients who need enteral nutrition. When compared to standard formulas, DSFs have shown superior performance in regulating HbA1c and insulin response in diabetes patients on enteral feed. Therefore, the adoption of diabetes-specific enteral feeding formulas presents benefits in terms of blood sugar control and comprehensive care for diabetes patients who require enteral nutrition.

Stage Insights

The adults segment accounted for the largest market share of 87.0% in 2025, owing to the increasing prevalence of nutritional deficiency and malnutrition among the adult population. Adult age group is more prone to reduced muscle strength, vitamins, and calcium deficiency among the women population of the age group above 30 years, apathy, lower immunity, hypertension, and fatigue. This leads to nutritional deficiency among the adult population. According to the OECD, India, Sri Lanka, Pakistan, and Bangladesh are prominent contributors to the global burden.

The adults segment is also anticipated to grow the fastest over the forecast period. Globally, the total cases of diabetes in adults have seen a rise due to growing urbanization, sedentary lifestyles, and unhealthy eating habits. Physical inactivity is a popular trend seen in the adult population and contributes to poor blood sugar control, weight gain, and insulin resistance. The rise in geriatric population is also a major factor contributing to segment growth.

Sales Channel Insights

The institutional sales segment dominated the market with over 38.5% revenue share in 2025. The sales channel includes commercial sales to government organizations, hospitals, and research institutes. The rising prevalence of diseases and advancements in hospital care lead to the rise in patient visits to hospitals, which drives the segment. Moreover, as patient awareness rises, the tendency to use official hospital channels for obtaining diabetes care nutrition prescriptions has also seen growth.

The online sales segment is anticipated to witness the fastest growth over the forecast period. The progress in telemedicine and ePharmacy has facilitated global distribution of clinical nutrition products, enabling manufacturers to expand their reach and cater to underrepresented communities. Hence, there is an increase in online sales due to the rising customer demand for diabetes care supplements via online platforms and stores.

Regional Insights

North America clinical nutrition for diabetes care market accounted for a share of approximately 34.0% in 2025. The large market share in the region is driven by a strong healthcare infrastructure, favorable reimbursement policies, and the presence of large clinical nutrition companies. Moreover, high public and private investment in healthcare and a shift towards holistic treatment regimens have aided the market growth in the region.

To learn more about this report, Download Free Sample Report

U.S. Clinical Nutrition for Diabetes Care Market Trends

The U.S. clinical nutrition market for diabetes care dominated the North American region with approximately 87% revenue share. The market for clinical nutrition for diabetes care is expanding swiftly worldwide; however, the U.S. leads the way due to its robust healthcare system and an increasing elderly population. The country is at the forefront of technological developments, specifically in healthcare.

Europe Clinical Nutrition for Diabetes Care Market Trends

Clinical nutrition for diabetes care market in Europe was the second-largest regional market in 2025. European guidelines by the Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), backed by scientific evidence to manage diabetes, stress the significance of eating plant-based foods that are minimally processed. By following evidence-based dietary recommendations and receiving individualized medical nutrition therapy (MNT), individuals with diabetes in Europe can effectively manage their condition, reduce complications, and improve their overall quality of life.

Germany clinical nutrition for diabetes care market dominated Europe in 2025 and is anticipated to witness lucrative growth over the forecast period. Healthcare facilities in Germany are known for their high-quality treatment of complications related to diabetes. They prioritize conservative treatments as much as possible and only opt for surgical procedures such as organ transplants when absolutely necessary. Furthermore, they use advanced diagnostic techniques and usage of personalized nutrition, which allow for the early identification and management of complications associated with diabetes, thereby improving the prognosis for patients.

Clinical nutrition for diabetes care market in UK is the second largest in Europe, and is anticipated to witness lucrative growth. In the UK, a range of diabetes medications are available, including metformin, sulphonylureas, DPP-4 inhibitors, SGLT2 inhibitors, and GLP-1 receptor agonists. These drugs are effective in controlling blood glucose levels and averting complications. The goal of these medications is to ward off immediate complications such as hypoglycemia and hyperglycemia, while also minimizing the risk of chronic complications like cardiovascular diseases and kidney problems.

These medications in combination with medical food are effective in the management of diabetes. In England, type 2 diabetes patients are exempt from paying for their medications, promoting adherence to their prescribed treatment plans due to the availability of free prescriptions. Such favorable government initiatives will further boost the country's market growth.

Asia Pacific Clinical Nutrition for Diabetes Care Market Trends

Clinical nutrition for diabetes care market in Asia Pacific is anticipated to record the fastest CAGR from 2026 to 2033. According to PubMed, the high incidence of diabetes in the Asia-Pacific region is a major issue, as over 60% of individuals with diabetes live in Asia, especially in nations such as China and India. With the rising prevalence of diabetes in the Asia-Pacific region, there is a growing recognition of the importance of implementing effective strategies to address these challenges including the effective nutritional management of patients suffering from diabetes.

China clinical nutrition for diabetes care market recorded the largest revenue share in Asia Pacific in 2025 and is expected to grow at a lucrative CAGR over the forecast period. In China, the usage of prescribed clinical nutrition varies depending on specific conditions and settings. The implementation of clinical nutrition in China is expanding, especially in the context of addressing malnutrition among older adults. The country also implemented a National Nutritional Plan aimed at educating the importance of dietary management from 2021 to 2033.

Clinical nutrition for diabetes care market in India is anticipated to witness the fastest growth during the forecast period. Clinical nutrition is essential in India, aiding the adoption of diets with proper glycemic control and lipid profiles. Baxter International Inc., a global leader in clinical nutrition, has led initiatives to raise awareness about proper nutrition for diabetes in India. Furthermore, in November 2025, Abbott Laboratories launched an advanced formulation of Ensure Diabetes Care in India, a clinically supported nutritional supplement designed to help manage blood glucose levels in people with diabetes. The product features a slow-release carbohydrate system along with high-quality protein and dietary fiber to support glycemic management, highlighting the growing focus on diabetes-specific clinical nutrition solutions.

Japan clinical nutrition market for diabetes care is a significant part of the Asia Pacific region and is expected to see lucrative growth during the forecast period. The consensus statement on ‘Pharmacotherapy in People with Type 2 Diabetes Mellitus’ by the Japan Diabetes Society emphasizes the need to take into account factors such as the patient’s metabolic imbalance, age, obesity, insulin secretion/insulin resistance, and chronic complications when choosing antidiabetic drugs and clinical nutrition formulas.

Key Clinical Nutrition for Diabetes Care Market Company Insights

The clinical nutrition market for diabetes market is concentrated, with prominent companies accounting for a large percentage. Companies in the diabetes clinical nutrition market are collaborating with regional players and expanding globally to expand their services and product portfolios. Some of the key clinical nutrition for diabetes care companies operating in the global market include Abbott Laboratories; Nestlé S.A.; Danone S.A.; Fresenius Kabi AG; and Mead Johnson & Company, LLC.

Global clinical nutrition for diabetes care market companies have resorted to varied strategic initiatives for sustained growth, such as mergers, collaborations, product development, and global and regional expansion. For instance, global players in the market are collaborating with local distributors and sales channels to expand their reach.

Clinical Nutrition for Diabetes Care Market Companies:

The following are the leading companies in the clinical nutrition for diabetes care market. These companies collectively hold the largest market share and dictate industry trends.

• Abbott Nutrition
• Pfizer Inc.
• Bayer AG
• Nestle Health Science S.A.
• GlaxoSmithKline plc
• Baxter International Inc.
• Otsuka Holdings Co., Ltd.
• Mead Johnson & Company, LLC
• Danone Nutricia
• Victus, Inc.

Recent Developments

• In May 2025, Danone completed the acquisition of a majority stake in Kate Farms, a U.S.-based provider of plant-based medical and specialized nutrition products. The acquisition strengthens Danone’s specialized nutrition portfolio, including products used in medical nutrition settings, and expands its reach among patients requiring disease-specific nutritional support.

• In October 2025, Nestlé Health Science announced a strategic partnership with the University of California, Davis Innovation Institute for Food & Health to accelerate innovation in nutrition and health science. The collaboration includes research in disease-specific nutrition areas such as chronic kidney disease, supporting the development of advanced nutritional solutions for patients with specialized health needs.

Global Clinical Nutrition for Diabetes Care Market Report Segmentation

This report forecasts revenue growth at the global, country, and regional levels, and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global clinical nutrition for diabetes care market report based on product, stage, sales channel, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral Nutrition
  • Parenteral Nutrition
  • Enteral Feeding Formulas
• Stage Outlook (Revenue, USD Million, 2021 - 2033)
  • Adult
  • Pediatric
• Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Online
  • Retail
  • Institutional Sales
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait